Dana McGinty, MD
Internal Medicine · Washington, DCNPI 1639195605
Payments from drug & device makers
Across 616 payments — averaging $76.01 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$37K
- AstraZeneca$2K
- Novo Nordisk$881
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$851
- Otsuka America Pharmaceutical, Inc.$823
- Boehringer Ingelheim$661
- plus $5K from 30 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 148 | $37,495 |
| AstraZeneca | 80 | $1,531 |
| Novo Nordisk | 55 | $881 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 37 | $851 |
| Otsuka America Pharmaceutical, Inc. | 38 | $823 |
| Boehringer Ingelheim | 24 | $661 |
| Pfizer | 34 | $640 |
| Lilly USA, LLC | 26 | $585 |
| Lundbeck LLC | 17 | $415 |
| Merck | 20 | $370 |
| Sunovion Pharmaceuticals Inc. | 20 | $368 |
| Abbott | 21 | $338 |
| Novartis | 15 | $264 |
| GSK | 11 | $256 |
| Takeda Pharmaceuticals U.S.A., Inc. | 12 | $171 |
| Alkermes, Inc. | 2 | $133 |
| Sanofi-aventis U.S. LLC | 6 | $117 |
| Biohaven Pharmaceutical Holding Company Ltd. | 6 | $110 |
| Bayer | 4 | $90 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 5 | $71 |
| Gilead | 3 | $65 |
| Idorsia Pharmaceuticals US Inc | 3 | $63 |
| Hikma Pharmaceuticals USA | 4 | $61 |
| Astellas Pharma US Inc | 3 | $57 |
| Amgen | 3 | $55 |
| MDD US Operations, LLC | 2 | $51 |
| Acerus Pharmaceuticals Corporation | 3 | $50 |
| Jazz Pharmaceuticals Inc. | 2 | $48 |
| Aytu Biopharma, Inc. | 2 | $41 |
| Teva Pharmaceuticals USA, Inc. | 2 | $36 |
| Arbor Pharmaceuticals, Inc. | 2 | $31 |
| Neurocrine Biosciences, Inc. | 1 | $25 |
| Clarus Therapeutics Inc. | 2 | $22 |
| Eisai Inc. | 1 | $18 |
| Biohaven Pharmaceuticals, Inc. | 1 | $17 |
| E.r. Squibb & Sons, L.L.C. | 1 | $16 |
How this compares
$46,825 in reported general payments places this provider in the 95th percentile of 645 internal medicine providers in District of Columbia.
See all internal medicine providers in District of Columbia →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other internal medicine in Washington
- Federico AschWashington$4.6M
- Geoffrey GibneyWashington$2.3M
- Nnemdi Kamanu EliasWashington$939K
- Andrea SingerWashington$930K
- Kathryn SowerwineWashington$831K
- Douglas WardWashington$454K
- Ida BergstromWashington$295K
- Miriam CameronWashington$290K
- Bruce RashbaumWashington$265K
- Kevin GriffithsWashington$180K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.